Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhuhai Keyu Biological Engineering develops and manufactures automated in vitro diagnostic analyzers—primarily for feces and urine—and associated reagents. Their flagship products include the KU series of fully automatic feces analyzers and various urine analyzers. These systems are widely adopted in Chinese hospitals to improve efficiency, reduce manual error, minimize cross-contamination risk, and automate routine laboratory workflows. The company holds over 70 patents for its technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhuhai Keyu Biological Engineering.